# Nexstim OY

- Location (FDA's records): Helsinki, FI
- FDA decisions: 4 (2009–2019): 4 510(k) clearances
- Names in FDA's records: Nexstim OY (2); Nexstim Plc (2)
- Product codes: GWF (2), OBP (2)
- Predicates its devices cite: 5 (2 its own); citations of its devices by later devices: 6 (2 its own)
- Recalls linked to its devices: 2 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Tonica Elektronik A/S: 1 (https://510kreport.com/company/tonica-elektronik-a-s)
- Radionics, Inc.: 1 (https://510kreport.com/company/radionics)
- The Magstim Company, Ltd.: 1 (https://510kreport.com/company/magstim)

## Firms that cite its devices most
- Surgiceye GmbH: 1 (https://510kreport.com/company/surgiceye)
- Magnus Medical, Inc.: 1 (https://510kreport.com/company/magnus-medical)
- Soterix Medical, Inc.: 1 (https://510kreport.com/company/soterix-medical)
- Localite GmbH: 1 (https://510kreport.com/company/localite)

## Its most-cited devices
- K171902: Nexstim Navigated Brain Therapy (NBT) System 2 (2017), cited by 3
- K091457: Nexstim Eximia Navigated Brain Stimulation System (2009), cited by 2
- K182700: Nexstim Navigated Brain Therapy (NBT) System 2 (2019), cited by 1

## Recent decisions
- K182700: Nexstim Navigated Brain Therapy (NBT) System 2 (Mar 22, 2019)
- K171902: Nexstim Navigated Brain Therapy (NBT) System 2 (Nov 10, 2017)
- K112881: Nexstim Navigated Brain Stimulation (NBS) System 4, Nexstim NBS System 4 with Nexspeech (TM) (May 22, 2012)
- K091457: Nexstim Eximia Navigated Brain Stimulation System (Dec 8, 2009)

Source page: https://510kreport.com/company/nexstim